Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...

Colorectal cancer is now the second leading cause of cancer deaths in the United States, and rates among adults under 50 continue to rise. While it’s still most common in older adults, it remains one ...

Researchers solved a long-standing mystery behind how a bacterial toxin associated with colorectal cancer damages the colon. The toxin first binds to a receptor called claudin-4, giving it access to ...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A new study looks into the differences in gut bacteria between people with and without colorectal cancer.